To substantiate the significance of primidone as an effective inhibitor of inflammatory RIPK1-dependent diseases, we extended our in vivo studies to a mouse model of SIRS, an entity of outstanding clinical relevance resembling septic shock. This evidence concerns the gene RIPK1 and systemic inflammatory response syndrome.